Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture

Clinica Chimica Acta

Volumn 413, Issue 21-23, 2012, Pages 1731-1736

  Jeong, Seri ^a   Park, Yongjung ^a   Cho, Yonggeun ^a   Kim, Hyon Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Bacteremia; Blood culture; C reactive protein; Contamination; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM CONTAMINATION; BLOOD CULTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TURBIDIMETRY;

AGED; AREA UNDER CURVE; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84864398626     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.06.030     Document Type: Article

References (35)

1. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
2. Bryan C.S. Clinical implications of positive blood cultures. Clin Microbiol Rev 1989, 2:329-353.
3. Kocoglu M.E., Bayram A., Balci I. Evaluation of negative results of BacT/Alert 3D automated blood culture system. J Microbiol 2005, 43:257-259.
4. Hall K.K., Lyman J.A. Updated review of blood culture contamination. Clin Microbiol Rev 2006, 19:788-802.
5. Bates D.W., Goldman L., Lee T.H. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA 1991, 265:365-369.
6. Pepys M.B., Baltz M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983, 34:141-212.
7. Povoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 2002, 28:235-243.
8. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
9. Reinhart K., Karzai W., Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000, 26:1193-1200.
10. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341:515-518.
11. Meisner M., Schmidt J., Huttner H., Tschaikowsky K. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000, 26(Suppl. 2):S212-S216.
12. Harbarth S., Holeckova K., Froidevaux C., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402.
13. Luyt C.E., Guerin V., Combes A., et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005, 171:48-53.
14. Stolz D., Christ-Crain M., Bingisser R., et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007, 131:9-19.
15. Rammaert B., Verdier N., Cavestri B., Nseir S. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease. Respirology 2009, 14:969-974.
16. Schuetz P., Christ-Crain M., Thomann R., et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302:1059-1066.
17. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29:530-538.
18. Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003, 31:1737-1741.
19. Muller B., Becker K.L., Schachinger H., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000, 28:977-983.
20. Selberg O., Hecker H., Martin M., Klos A., Bautsch W., Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000, 28:2793-2798.
21. Suprin E., Camus C., Gacouin A., et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 2000, 26:1232-1238.
22. Brunkhorst F.M., Wegscheider K., Forycki Z.F., Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000, 26(Suppl. 2):S148-S152.
23. Charles P.E., Ladoire S., Aho S., et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis 2008, 8:38.
24. Kim M.H., Lim G., Kang S.Y., Lee W.I., Suh J.T., Lee H.J. Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever. Yonsei Med J 2011, 52:276-281.
25. Smith J.W., Colombo J.L., McDonald T.L. Comparison of serum amyloid A and C-reactive protein as indicators of lung inflammation in corticosteroid treated and non-corticosteroid treated cystic fibrosis patients. J Clin Lab Anal 1992, 6:219-224.
26. Bossink A.W., Groeneveld A.B., Thijs L.G. Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 1999, 29:398-407.
27. Schuetz P., Mueller B., Trampuz A. Serum procalcitonin for discrimination of blood contamination from bloodstream infection due to coagulase-negative staphylococci. Infection 2007, 35:352-355.
28. Linscheid P., Seboek D., Nylen E.S., et al. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003, 144:5578-5584.
29. Muller B., White J.C., Nylen E.S., Snider R.H., Becker K.L., Habener J.F. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001, 86:396-404.
30. Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998, 24:680-684.
31. Wanner G.A., Keel M., Steckholzer U., Beier W., Stocker R., Ertel W. Relationship between procalcitonin plasma concentrations and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000, 28:950-957.
32. Meisner M., Rauschmayer C., Schmidt J., et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002, 28:1094-1102.
33. Sauerland S., Hensler T., Bouillon B., et al. Plasma concentrations of procalcitonin and neopterin in multiple trauma patients with or without brain injury. J Neurotrauma 2003, 20:953-960.
34. Liaudat S., Dayer E., Praz G., Bille J., Troillet N. Usefulness of procalcitonin serum concentration for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001, 20:524-527.
35. Andreola B., Bressan S., Callegaro S., Liverani A., Plebani M., Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J 2007, 26:672-677.